Li Dongxu, Zhang Zhao, Li Mengsi
Department of Cardiovascular Surgery.
Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, PR China.
Medicine (Baltimore). 2020 Jan;99(4):e18901. doi: 10.1097/MD.0000000000018901.
Surgical treatments for ventricular septal defects (VSDs) mainly include 3 approaches: conventional surgical repair (CSR), transcatheter device closure (TDC), and perventricualr device closure (PDC). PDC has been introduced in over 10 years, although there remain concerns about adverse events. This network meta-analysis is to compare PDC, CSR, and TDC in the treatment of congenital VSD.
We will search MEDLINE, EMBASE, Clinical Trials, Cochrane Library, and China National Knowledge Infrastructure databases for comparative studies on device closure and conventional repair for congenital VSDs to August 2019. A network meta-analysis with frequentist frame will be performed to compare the 3 approaches involving the success rate, in-hospital indexes, and incidences of complications, using risk ratio with 95% confidence intervals.
This study will be submitted to a peer-reviewed journal for publication.
This network meta-analysis will assess the safety and efficacy of PDC, CSR, and TDC in the treatment of congenital VSDs, and provide more evidence-based guidance in clinical practice.
CRD42019125257.
室间隔缺损(VSD)的外科治疗主要包括三种方法:传统外科修复(CSR)、经导管装置封堵(TDC)和经心室装置封堵(PDC)。PDC已应用超过10年,尽管对不良事件仍存在担忧。这项网状Meta分析旨在比较PDC、CSR和TDC治疗先天性VSD的效果。
我们将检索MEDLINE、EMBASE、临床试验、Cochrane图书馆和中国知网数据库,查找截至2019年8月关于先天性VSD装置封堵和传统修复的比较研究。将进行一个采用频率学派框架的网状Meta分析,以比较这三种方法在成功率、住院指标和并发症发生率方面的差异,使用风险比及95%置信区间。
本研究将提交给同行评审期刊发表。
这项网状Meta分析将评估PDC、CSR和TDC治疗先天性VSD的安全性和有效性,并在临床实践中提供更多基于证据的指导。
PROSPERO注册号:CRD42019125257。